Table 3. Overlapping IPA Pathways Associated with Expression of Mesenchymal Signature Genes and Genes Up-regulated in IL13Rα2-positive Cell Lines and IL13Rα2 Over-expressing Patient Samples.
IPA-defined Pathway* | Mesenchymal Signature Genes (FDR) | IL13Rα2-positive Cell Lines (FDR) | IL13Rα2 Over-expressing Patient Samples (FDR) |
---|---|---|---|
Hepatic Fibrosis / Hepatic Stellate Cell Activation | 0.0000054 | 0.00021 | 0.0012 |
TREM1 Signaling | 0.000072 | 0.0036 | 0.0021 |
Dendritic Cell Maturation | 0.000079 | 0.049 | 0.020 |
Integrin Signaling | 0.00096 | 0.0068 | 0.014 |
Agrin Interactions at Neuromuscular Junction | 0.0033 | 0.045 | 0.031 |
Caveolar-mediated Endocytosis Signaling | 0.016 | 0.00062 | 0.012 |
Type I Diabetes Mellitus Signaling | 0.016 | 0.0091 | 0.0036 |
Death Receptor Signaling | 0.030 | 0.0036 | 0.012 |
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis | 0.042 | 0.034 | 0.019 |
Top overlapping IPA pathways with FDR < 0.05. Immune function-related pathways are indicated in bold.